TY - JOUR
T1 - A Comparison of Automatically Extracted Quantitative EEG Features for Seizure Risk Stratification in Neonatal Encephalopathy
AU - Keene, Jennifer C.
AU - Loe, Maren E.
AU - Fulton, Talie
AU - Keene, Maire
AU - Morrissey, Michael J.
AU - Tomko, Stuart R.
AU - Vesoulis, Zachary A.
AU - Zempel, John M.
AU - Ching, Shi Nung
AU - Guerriero, Réjean M.
N1 - Publisher Copyright:
Copyright © 2024 by the American Clinical Neurophysiology Society.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Purpose: Seizures occur in up to 40% of neonates with neonatal encephalopathy. Earlier identification of seizures leads to more successful seizure treatment, but is often delayed because of limited availability of continuous EEG monitoring. Clinical variables poorly stratify seizure risk, and EEG use to stratify seizure risk has previously been limited by need for manual review and artifact exclusion. The goal of this study is to compare the utility of automatically extracted quantitative EEG (qEEG) features for seizure risk stratification. Methods: We conducted a retrospective analysis of neonates with moderate-to-severe neonatal encephalopathy who underwent therapeutic hypothermia at a single center. The first 24 hours of EEG underwent automated artifact removal and qEEG analysis, comparing qEEG features for seizure risk stratification. Results: The study included 150 neonates and compared the 36 (23%) with seizures with those without. Absolute spectral power best stratified seizure risk with area under the curve ranging from 63% to 71%, followed by range EEG lower and upper margin, median and SD of the range EEG lower margin. No features were significantly more predictive in the hour before seizure onset. Clinical examination was not associated with seizure risk. Conclusions: Automatically extracted qEEG features were more predictive than clinical examination in stratifying neonatal seizure risk during therapeutic hypothermia. qEEG represents a potential practical bedside tool to individualize intensity and duration of EEG monitoring and decrease time to seizure recognition. Future work is needed to refine and combine qEEG features to improve risk stratification.
AB - Purpose: Seizures occur in up to 40% of neonates with neonatal encephalopathy. Earlier identification of seizures leads to more successful seizure treatment, but is often delayed because of limited availability of continuous EEG monitoring. Clinical variables poorly stratify seizure risk, and EEG use to stratify seizure risk has previously been limited by need for manual review and artifact exclusion. The goal of this study is to compare the utility of automatically extracted quantitative EEG (qEEG) features for seizure risk stratification. Methods: We conducted a retrospective analysis of neonates with moderate-to-severe neonatal encephalopathy who underwent therapeutic hypothermia at a single center. The first 24 hours of EEG underwent automated artifact removal and qEEG analysis, comparing qEEG features for seizure risk stratification. Results: The study included 150 neonates and compared the 36 (23%) with seizures with those without. Absolute spectral power best stratified seizure risk with area under the curve ranging from 63% to 71%, followed by range EEG lower and upper margin, median and SD of the range EEG lower margin. No features were significantly more predictive in the hour before seizure onset. Clinical examination was not associated with seizure risk. Conclusions: Automatically extracted qEEG features were more predictive than clinical examination in stratifying neonatal seizure risk during therapeutic hypothermia. qEEG represents a potential practical bedside tool to individualize intensity and duration of EEG monitoring and decrease time to seizure recognition. Future work is needed to refine and combine qEEG features to improve risk stratification.
KW - Biomarker
KW - Neonatal critical care
KW - Neonatal encephalopathy
KW - Neonatal seizures
KW - Quantitative EEG
UR - https://www.scopus.com/pages/publications/85214552572
U2 - 10.1097/WNP.0000000000001067
DO - 10.1097/WNP.0000000000001067
M3 - Article
C2 - 38857366
AN - SCOPUS:85214552572
SN - 0736-0258
VL - 42
SP - 57
EP - 63
JO - Journal of Clinical Neurophysiology
JF - Journal of Clinical Neurophysiology
IS - 1
ER -